Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Fr | Greenbrook TMS Inc. - 8-K, Current Report | - | SEC Filings | ||
02.04. | Greenbrook TMS Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 1 | SEC Filings | ||
01.04. | Greenbrook TMS Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 1 | SEC Filings | ||
26.03. | Greenbrook TMS Inc. - 8-K, Current Report | 1 | SEC Filings | ||
15.03. | Greenbrook TMS Inc. - 8-K, Current Report | 1 | SEC Filings | ||
04.03. | Greenbrook TMS Inc.: Greenbrook Appoints Chief Operating Officer | 69 | PR Newswire | TORONTO, March 4, 2024 /PRNewswire/ - Greenbrook TMS Inc. (OTC Pink: GBNHF) ("Greenbrook" or the "Company") announced today the appointment of Andrew Crish as Chief Operating Officer, effective... ► Artikel lesen | |
01.03. | Greenbrook TMS Inc. - 8-K, Current Report | - | SEC Filings | ||
23.02. | Greenbrook TMS to be delisted from Nasdaq on February 26 | 1 | Investing.com | ||
23.02. | Greenbrook TMS to delist shares from Nasdaq | 1 | Seeking Alpha | ||
23.02. | Greenbrook TMS Inc. Announces Delisting From Nasdaq | 277 | PR Newswire | TORONTO, Feb. 23, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced receipt of the final delisting notice from the Listing Qualifications Department... ► Artikel lesen | |
22.02. | Greenbrook TMS Inc. - 8-K, Current Report | 1 | SEC Filings | ||
22.02. | Why Greenbrook (GBNH) Stock Is Trading Sharply Lower | 1 | Benzinga.com | ||
22.02. | Greenbrook TMS announces $1.2 million direct offering | 1 | Investing.com | ||
21.02. | Why Is Greenbrook TMS (GBNH) Stock Up 174% Today? | 2 | InvestorPlace | ||
15.02. | Greenbrook Tms Raises Us$2.5 Million In Debt Financing | 2 | CNW | ||
09.02. | Greenbrook TMS Inc. - 8-K, Current Report | - | SEC Filings | ||
07.02. | Greenbrook TMS secures $1.5 million in additional loans | - | Investing.com | ||
06.02. | Greenbrook Tms Raises Us$1.5 Million In Debt Financing | - | CNW | ||
02.02. | Greenbrook TMS Inc. - 8-K, Current Report | 1 | SEC Filings | ||
29.01. | Greenbrook TMS Inc.: Greenbrook Appoints Peter Willett As Chief Financial Officer | 178 | PR Newswire | TORONTO, Jan. 29, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced that the Company's Board of Directors has appointed Mr. Peter Willett as... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ORPEA | 11,854 | -4,82 % | EMEIS PURSUES ITS REFOUNDATION: 2023 Consolidated Financial Results of ORPEA S.A. | Significant improvement in non-financial indicators, with major advances for employees, residents and patients
Health and safety: decline in the work-related accident frequency rate, at 24.8... ► Artikel lesen | |
NANO-X IMAGING | 8,940 | -1,76 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
BUTTERFLY NETWORK | 0,700 | -1,05 % | ThinkSono Ltd: ThinkSono Releases Real-Time DVT AI Training Solution for Butterfly Network's Handheld Ultrasound Devices | LONDON, ENGLAND / ACCESSWIRE / April 23, 2024 / ThinkSono, a pioneering provider of AI-driven medical imaging solutions, is proud to announce the release of ThinkSono AI Training, a deep vein thrombosis... ► Artikel lesen | |
GOODRX | 6,995 | +0,50 % | GoodRx Reports Fourth Quarter and Full Year 2023 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., has released its financial... ► Artikel lesen | |
JOINT CORP | 12,020 | -2,12 % | The Joint Corp. to Host Conference Call on Thursday, May 2nd to Discuss First Quarter 2024 Results | ||
CARMAT | 3,150 | -13,93 % | CARMAT Announces Its 2023 Annual Results and Provides an Update on Its Progress and Prospects for 2024 | 2023 sales of €2.8 million, i.e. 17 Aeson® implants, including 11 in the last quarter
2024 sales forecast of around €14 million
Active exploration of financing options to extend... ► Artikel lesen | |
HYPERFINE | 0,810 | 0,00 % | Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | GUILFORD, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
PROGYNY | 32,230 | -1,14 % | Progyny, Inc. Announces Third Quarter 2023 Results | Record Quarterly Revenue of $280.9 Million, Reflecting 37% Growth Over the Prior Year PeriodRaises Full Year Revenue and Earnings GuidanceStrong Sales Season Produces 1.3 Million New Covered Lives... ► Artikel lesen | |
MIMEDX | 6,145 | -4,43 % | Mimedx Group, Cyclacel Pharmaceuticals, Predictive Oncology among healthcare movers | ||
BIOMERICA | 0,670 | -6,03 % | Biomerica, Inc.: Biomerica Reports Third Quarter 2024 Financial Results | Fiscal Discipline Leads to Improvement as Loss per Share Narrows to $0.27 from $0.40 Amidst Sales Force Expansion for the Nine Months in Fiscal 2024 InFoods IBS Positive Clinical Data to be Presented... ► Artikel lesen | |
ATRION | 394,00 | +4,79 % | Dividendenbekanntmachungen (14.03.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN PLC GB00BF8Q6K64 0,073 GBP 0,0853 EUR ABRDN PLC ADR US00108N1000 0,3203 USD 0,2925 EUR ACCO BRANDS CORPORATION US00081T1088 0... ► Artikel lesen | |
ATRICURE | 22,490 | -2,43 % | AtriCure upgraded at Oppenheimer on valuation | ||
CASTLE BIOSCIENCES | 19,430 | -2,17 % | Castle Biosciences Inc.: Presentations at EADO Highlight Potential Impact of Castle Biosciences' DecisionDx-Melanoma and DecisionDx-SCC Tests on the Management of Patients with Skin Cancer | If choosing to use a molecular test to rule-out a sentinel lymph node biopsy (SLNB) in patients diagnosed with melanoma, it is important to show that patients foregoing an SLNB have low risk outcomes... ► Artikel lesen | |
AMWELL | 0,532 | +0,11 % | Amwell Receives Continued Listing Standard Notice From NYSE | Boston, April 04, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of healthcare software as a service, today announced that it received a notice on April 2, 2024 from the New York... ► Artikel lesen | |
TALKSPACE | 3,100 | +0,98 % | Talkspace Announces Third Quarter 2023 Results | B2B payor revenue grew 132% year-over-year 3Q 2023 Operating expenses of $24.0 million, down 30% year-over-year Reduced Net Loss to $4.4 million and Adjusted EBITDA1 loss to $2.8 million, an improvement... ► Artikel lesen |